Inmed Pharmaceuticals Inc (INM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 09-2019 | 06-2019 | |
| Operating Expenses | 2,880 | 0 |
| Operating Income | -2,880 | N/A |
| Other Income | 74 | 0 |
| Pre-tax Income | -2,805 | 0 |
| Net Income Continuous | -2,805 | N/A |
| Net Income | $-2,805 | $N/A |
| EPS Basic Total Ops | -270.00 | N/A |
| EPS Basic Continuous Ops | -268.67 | N/A |
| EPS Diluted Total Ops | -270.00 | N/A |
| EPS Diluted Continuous Ops | -268.67 | N/A |
| EBITDA(a) | $-2,849 | $N/A |